Pharmafile Logo

Abstract Highlights from EHA 2022 : A Spotlight on Lymphoma

- PMLiVE

Spotlight on Lymphoma

Ahead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in lymphoma. Here are some of the highlights…

  1. Update on the ECHELON-1 study in frontline Hodgkin lymphoma, where an OS advantage was seen when bleomycin was replaced with brentuximab vedotin in frontline, ABVD, which is potentially practice-changing.
  2. The results of the Ph 3 SHINE study have been eagerly awaited for many years in untreated mantle cell lymphoma, and showed a significant improvement in PFS with ibrutinib + bendamustine + rituximab and rituximab maintenance vs standard chemoimmunotherapy.
  3. Positive Ph 2 efficacy data with the bispecific antibodies, glofitamab for relapsed/refractory (R/R) diffuse large B-cell lymphoma, and mosunetuzumab for R/R follicular lymphoma, building on the Ph 1 data previously reported.
  4. Other CAR T-cell therapies with novel targets and in other indications are emerging, such as for T-cell lymphoma where there is a high unmet need for new therapies. Some manipulations to manufacturing also result in an auto CAR within 2 days. So, while CAR T-cell therapy is not new, there are new implementations of therapy that have been around for several years.
  5. Important to now learn regarding patient selection, sequencing CD19 directed therapy and how to account for the patient experience for which there will also be more PRO data reported.

You can also watch the full video here

About Medscape:
Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide. Medscape is the leading online global destination for physicians and healthcare professionals, providing over 5 million members with the latest medical news, expert opinion, and precision education (CME and CPD) to improve clinical practice and advance health outcomes. Medscape’s unrivalled membership reach and therapeutic expertise deliver education across 30+ specialties in 40+ learning formats, using the latest digital and live technology.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Advancing Patient-Centered Cancer Care Through Education to #CloseTheCareGap

One of the next frontiers in oncology isn’t being explored in a lab. Instead, it’s advancing in hospitals and private clinics around the world, thanks to the hard work of...

Medscape Education’s Dedication to Delivering Impact to be Highlighted at Alliance Annual Meeting 2024

Being an active part of the continuing medical education community is a top priority for the Medscape Education team. As part of their commitment to sharing their insights and learnings...

We Can Shorten the Journey

During the shortest month of the year, Medscape Education is making a renewed commitment to use clinician education to help shorten the diagnostic and treatment journey for the millions of...

Making an Impact at ASH 2023

Medscape has left behind the sunny skies of San Deigo, having attended their final conference of the year at the ASH annual meeting.The team wrapped up the year with a...

Women’s Health Faces Some Difficult Headwinds. Here’s How We Can Move Forward

When it comes to women’s health, “we are a bit behind — almost where oncology was 20 years ago and neuroscience was about 10 years ago,” says Sandra Milligan, Head...

A “Leaky Pipeline” and the Loss of Talented Female Physicians

A leaky pipeline that begins during medical school and extends throughout the training process means we lose many talented women, says Fatima Rodriguez, director of preventive cardiology and associate professor...

Medscape Oncology’s Large Presence at ASH 2023

Medscape Education is returning to the annual ASH conference with eight symposia, two publications, and the opportunity for clinicians to challenge their knowledge with MedChallenge.The eight symposia will be held...